APO Research

APO RESEARCH · REPORT

Cell Engineering Service

Selected research

Market Analysis & Forecast

Global Cell Engineering Service Market Analysis and Forecast 2026-2032

Market perspective

The global Cell Engineering Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cell Engineering Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cell Engineering Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cell Engineering Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cell Engineering Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cell Engineering Service include Portal Biotechnologies, Lonza Group, Thermo Fisher Scientific, Sartorius, GenScript, Metagenomi, CorrectSequence Therapeutics and Eddie Gene, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cell Engineering Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cell Engineering Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Cell Engineering Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cell Engineering Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cell Engineering Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cell Engineering Service revenue, projected growth trends, production technology, application and end-user industry.

Cell Engineering Service Segment by Company

Portal Biotechnologies

Lonza Group

Thermo Fisher Scientific

Sartorius

GenScript

Metagenomi

CorrectSequence Therapeutics

Eddie Gene

Cell Engineering Service Segment by Type

Gene Editing

Cell Line Development

Others

Cell Engineering Service Segment by Application

Medical Industry

Scientific Research

Others

Cell Engineering Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Engineering Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell Engineering Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Engineering Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cell Engineering Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cell Engineering Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Engineering Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell Engineering Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Gene Editing Major Player Table 3. Cell Line Development Major Player Table 4. Others Major Player Table 5. Global Cell Engineering Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Medical Industry Major Player Table 7. Scientific Research Major Player Table 8. Others Major Player Table 9. Cell Engineering Service Industry Trends Table 10. Cell Engineering Service Industry Drivers Table 11. Cell Engineering Service Industry Opportunities and Challenges Table 12. Cell Engineering Service Industry Restraints Table 13. Global Cell Engineering Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Cell Engineering Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Cell Engineering Service Market Share by Region (2021-2026) Table 16. Global Cell Engineering Service Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Cell Engineering Service Market Share by Region (2027-2032) Table 18. Global Cell Engineering Service Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Cell Engineering Service Revenue Market Share by Players (2021-2026) Table 20. Global Cell Engineering Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Cell Engineering Service Key Players Headquarters & Area Served Table 22. Global Cell Engineering Service Players, Product Type & Application Table 23. Global Cell Engineering Service Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Cell Engineering Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Cell Engineering Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Cell Engineering Service Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Cell Engineering Service Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Cell Engineering Service Revenue Market Share by Type (2021-2026) Table 30. Global Cell Engineering Service Revenue Market Share by Type (2027-2032) Table 31. Global Cell Engineering Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Cell Engineering Service Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Cell Engineering Service Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Cell Engineering Service Revenue Market Share by Application (2021-2026) Table 35. Global Cell Engineering Service Revenue Market Share by Application (2027-2032) Table 36. Portal Biotechnologies Company Information Table 37. Portal Biotechnologies Business Overview Table 38. Portal Biotechnologies Cell Engineering Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Portal Biotechnologies Cell Engineering Service Product Portfolio Table 40. Portal Biotechnologies Recent Development Table 41. Lonza Group Company Information Table 42. Lonza Group Business Overview Table 43. Lonza Group Cell Engineering Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Lonza Group Cell Engineering Service Product Portfolio Table 45. Lonza Group Recent Development Table 46. Thermo Fisher Scientific Company Information Table 47. Thermo Fisher Scientific Business Overview Table 48. Thermo Fisher Scientific Cell Engineering Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Thermo Fisher Scientific Cell Engineering Service Product Portfolio Table 50. Thermo Fisher Scientific Recent Development Table 51. Sartorius Company Information Table 52. Sartorius Business Overview Table 53. Sartorius Cell Engineering Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Sartorius Cell Engineering Service Product Portfolio Table 55. Sartorius Recent Development Table 56. GenScript Company Information Table 57. GenScript Business Overview Table 58. GenScript Cell Engineering Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. GenScript Cell Engineering Service Product Portfolio Table 60. GenScript Recent Development Table 61. Metagenomi Company Information Table 62. Metagenomi Business Overview Table 63. Metagenomi Cell Engineering Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Metagenomi Cell Engineering Service Product Portfolio Table 65. Metagenomi Recent Development Table 66. CorrectSequence Therapeutics Company Information Table 67. CorrectSequence Therapeutics Business Overview Table 68. CorrectSequence Therapeutics Cell Engineering Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. CorrectSequence Therapeutics Cell Engineering Service Product Portfolio Table 70. CorrectSequence Therapeutics Recent Development Table 71. Eddie Gene Company Information Table 72. Eddie Gene Business Overview Table 73. Eddie Gene Cell Engineering Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Eddie Gene Cell Engineering Service Product Portfolio Table 75. Eddie Gene Recent Development Table 76. North America Cell Engineering Service Revenue by Type (2021-2026) & (US$ Million) Table 77. North America Cell Engineering Service Revenue by Type (2027-2032) & (US$ Million) Table 78. North America Cell Engineering Service Revenue by Application (2021-2026) & (US$ Million) Table 79. North America Cell Engineering Service Revenue by Application (2027-2032) & (US$ Million) Table 80. North America Cell Engineering Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Cell Engineering Service Revenue by Country (2021-2026) & (US$ Million) Table 82. North America Cell Engineering Service Revenue by Country (US$ Million) & (2027-2032) Table 83. Europe Cell Engineering Service Revenue by Type (2021-2026) & (US$ Million) Table 84. Europe Cell Engineering Service Revenue by Type (2027-2032) & (US$ Million) Table 85. Europe Cell Engineering Service Revenue by Application (2021-2026) & (US$ Million) Table 86. Europe Cell Engineering Service Revenue by Application (2027-2032) & (US$ Million) Table 87. Europe Cell Engineering Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Europe Cell Engineering Service Revenue by Country (2021-2026) & (US$ Million) Table 89. Europe Cell Engineering Service Revenue by Country (US$ Million) & (2027-2032) Table 90. China Cell Engineering Service Revenue by Type (2021-2026) & (US$ Million) Table 91. China Cell Engineering Service Revenue by Type (2027-2032) & (US$ Million) Table 92. China Cell Engineering Service Revenue by Application (2021-2026) & (US$ Million) Table 93. China Cell Engineering Service Revenue by Application (2027-2032) & (US$ Million) Table 94. Asia Cell Engineering Service Revenue by Type (2021-2026) & (US$ Million) Table 95. Asia Cell Engineering Service Revenue by Type (2027-2032) & (US$ Million) Table 96. Asia Cell Engineering Service Revenue by Application (2021-2026) & (US$ Million) Table 97. Asia Cell Engineering Service Revenue by Application (2027-2032) & (US$ Million) Table 98. Asia Cell Engineering Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Asia Cell Engineering Service Revenue by Region (US$ Million) & (2021-2026) Table 100. Asia Cell Engineering Service Revenue by Region (US$ Million) & (2027-2032) Table 101. SAMEA Cell Engineering Service Revenue by Type (2021-2026) & (US$ Million) Table 102. SAMEA Cell Engineering Service Revenue by Type (2027-2032) & (US$ Million) Table 103. SAMEA Cell Engineering Service Revenue by Application (2021-2026) & (US$ Million) Table 104. SAMEA Cell Engineering Service Revenue by Application (2027-2032) & (US$ Million) Table 105. SAMEA Cell Engineering Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. SAMEA Cell Engineering Service Revenue by Country (2021-2026) & (US$ Million) Table 107. SAMEA Cell Engineering Service Revenue by Country (US$ Million) & (2027-2032) Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Cell Engineering Service Image Figure 2. Global Cell Engineering Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell Engineering Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Gene Editing Image Figure 5. Cell Line Development Image Figure 6. Others Image Figure 7. Global Cell Engineering Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Cell Engineering Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Medical Industry Image Figure 10. Scientific Research Image Figure 11. Others Image Figure 12. Global Cell Engineering Service Market Size (US$ Million) & (2021-2032) Figure 13. Global Cell Engineering Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Cell Engineering Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Cell Engineering Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Cell Engineering Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Cell Engineering Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Cell Engineering Service Revenue Market Share by Type (2021-2032) Figure 20. Global Cell Engineering Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Cell Engineering Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Cell Engineering Service Revenue Market Share by Application (2021-2032) Figure 23. North America Cell Engineering Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Cell Engineering Service Revenue Share by Type (2021-2032) Figure 25. North America Cell Engineering Service Revenue Share by Application (2021-2032) Figure 26. North America Cell Engineering Service Revenue Share by Country (2021-2032) Figure 27. United States Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Cell Engineering Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Cell Engineering Service Revenue Share by Type (2021-2032) Figure 32. Europe Cell Engineering Service Revenue Share by Application (2021-2032) Figure 33. Europe Cell Engineering Service Revenue Share by Country (2021-2032) Figure 34. Germany Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Cell Engineering Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Cell Engineering Service Revenue Share by Type (2021-2032) Figure 44. China Cell Engineering Service Revenue Share by Application (2021-2032) Figure 45. Asia Cell Engineering Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Cell Engineering Service Revenue Share by Type (2021-2032) Figure 47. Asia Cell Engineering Service Revenue Share by Application (2021-2032) Figure 48. Asia Cell Engineering Service Revenue Share by Region (2021-2032) Figure 49. Japan Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Cell Engineering Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Cell Engineering Service Revenue Share by Type (2021-2032) Figure 57. SAMEA Cell Engineering Service Revenue Share by Application (2021-2032) Figure 58. SAMEA Cell Engineering Service Revenue Share by Country (2021-2032) Figure 59. Brazil Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Cell Engineering Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Editing
  • Cell Line Development
  • Others
Applications
  • Medical Industry
  • Scientific Research
  • Others
Companies covered
  • Portal Biotechnologies
  • Lonza Group
  • Thermo Fisher Scientific
  • Sartorius
  • GenScript
  • Metagenomi
  • CorrectSequence Therapeutics
  • Eddie Gene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cell Engineering Service Market by Type
  3. 1.2.1 Global Cell Engineering Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Gene Editing
  5. 1.2.3 Cell Line Development
  6. 1.2.4 Others
  7. 1.3 Cell Engineering Service Market by Application
  8. 1.3.1 Global Cell Engineering Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Medical Industry
  10. 1.3.3 Scientific Research
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Cell Engineering Service Market Dynamics
  1. 2.1 Cell Engineering Service Industry Trends
  2. 2.2 Cell Engineering Service Industry Drivers
  3. 2.3 Cell Engineering Service Industry Opportunities and Challenges
  4. 2.4 Cell Engineering Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cell Engineering Service Market Perspective (2021-2032)
  2. 3.2 Global Cell Engineering Service Growth Trends by Region
  3. 3.2.1 Global Cell Engineering Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cell Engineering Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Cell Engineering Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cell Engineering Service Revenue by Players
  2. 4.1.1 Global Cell Engineering Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Cell Engineering Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cell Engineering Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cell Engineering Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cell Engineering Service Key Players Headquarters & Area Served
  7. 4.4 Global Cell Engineering Service Players, Product Type & Application
  8. 4.5 Global Cell Engineering Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cell Engineering Service Market CR5 and HHI
  11. 4.6.3 2025 Cell Engineering Service Tier 1, Tier 2, and Tier 3
5 Cell Engineering Service Market Size by Type
  1. 5.1 Global Cell Engineering Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell Engineering Service Revenue by Type (2021-2032)
  3. 5.3 Global Cell Engineering Service Revenue Market Share by Type (2021-2032)
6 Cell Engineering Service Market Size by Application
  1. 6.1 Global Cell Engineering Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cell Engineering Service Revenue by Application (2021-2032)
  3. 6.3 Global Cell Engineering Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Portal Biotechnologies
  2. 7.1.1 Portal Biotechnologies Company Information
  3. 7.1.2 Portal Biotechnologies Business Overview
  4. 7.1.3 Portal Biotechnologies Cell Engineering Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Portal Biotechnologies Cell Engineering Service Product Portfolio
  6. 7.1.5 Portal Biotechnologies Recent Developments
  7. 7.2 Lonza Group
  8. 7.2.1 Lonza Group Company Information
  9. 7.2.2 Lonza Group Business Overview
  10. 7.2.3 Lonza Group Cell Engineering Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Lonza Group Cell Engineering Service Product Portfolio
  12. 7.2.5 Lonza Group Recent Developments
  13. 7.3 Thermo Fisher Scientific
  14. 7.3.1 Thermo Fisher Scientific Company Information
  15. 7.3.2 Thermo Fisher Scientific Business Overview
  16. 7.3.3 Thermo Fisher Scientific Cell Engineering Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Thermo Fisher Scientific Cell Engineering Service Product Portfolio
  18. 7.3.5 Thermo Fisher Scientific Recent Developments
  19. 7.4 Sartorius
  20. 7.4.1 Sartorius Company Information
  21. 7.4.2 Sartorius Business Overview
  22. 7.4.3 Sartorius Cell Engineering Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Sartorius Cell Engineering Service Product Portfolio
  24. 7.4.5 Sartorius Recent Developments
  25. 7.5 GenScript
  26. 7.5.1 GenScript Company Information
  27. 7.5.2 GenScript Business Overview
  28. 7.5.3 GenScript Cell Engineering Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 GenScript Cell Engineering Service Product Portfolio
  30. 7.5.5 GenScript Recent Developments
  31. 7.6 Metagenomi
  32. 7.6.1 Metagenomi Company Information
  33. 7.6.2 Metagenomi Business Overview
  34. 7.6.3 Metagenomi Cell Engineering Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Metagenomi Cell Engineering Service Product Portfolio
  36. 7.6.5 Metagenomi Recent Developments
  37. 7.7 CorrectSequence Therapeutics
  38. 7.7.1 CorrectSequence Therapeutics Company Information
  39. 7.7.2 CorrectSequence Therapeutics Business Overview
  40. 7.7.3 CorrectSequence Therapeutics Cell Engineering Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 CorrectSequence Therapeutics Cell Engineering Service Product Portfolio
  42. 7.7.5 CorrectSequence Therapeutics Recent Developments
  43. 7.8 Eddie Gene
  44. 7.8.1 Eddie Gene Company Information
  45. 7.8.2 Eddie Gene Business Overview
  46. 7.8.3 Eddie Gene Cell Engineering Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Eddie Gene Cell Engineering Service Product Portfolio
  48. 7.8.5 Eddie Gene Recent Developments
8 North America
  1. 8.1 North America Cell Engineering Service Revenue (2021-2032)
  2. 8.2 North America Cell Engineering Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Cell Engineering Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Cell Engineering Service Revenue by Type (2027-2032)
  5. 8.3 North America Cell Engineering Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Cell Engineering Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Cell Engineering Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Cell Engineering Service Revenue by Application (2027-2032)
  9. 8.5 North America Cell Engineering Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Cell Engineering Service Revenue by Country
  11. 8.6.1 North America Cell Engineering Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cell Engineering Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Cell Engineering Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cell Engineering Service Revenue (2021-2032)
  2. 9.2 Europe Cell Engineering Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cell Engineering Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cell Engineering Service Revenue by Type (2027-2032)
  5. 9.3 Europe Cell Engineering Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cell Engineering Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cell Engineering Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cell Engineering Service Revenue by Application (2027-2032)
  9. 9.5 Europe Cell Engineering Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cell Engineering Service Revenue by Country
  11. 9.6.1 Europe Cell Engineering Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cell Engineering Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cell Engineering Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cell Engineering Service Revenue (2021-2032)
  2. 10.2 China Cell Engineering Service Revenue by Type (2021-2032)
  3. 10.2.1 China Cell Engineering Service Revenue by Type (2021-2026)
  4. 10.2.2 China Cell Engineering Service Revenue by Type (2027-2032)
  5. 10.3 China Cell Engineering Service Revenue Share by Type (2021-2032)
  6. 10.4 China Cell Engineering Service Revenue by Application (2021-2032)
  7. 10.4.1 China Cell Engineering Service Revenue by Application (2021-2026)
  8. 10.4.2 China Cell Engineering Service Revenue by Application (2027-2032)
  9. 10.5 China Cell Engineering Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cell Engineering Service Revenue (2021-2032)
  2. 11.2 Asia Cell Engineering Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cell Engineering Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cell Engineering Service Revenue by Type (2027-2032)
  5. 11.3 Asia Cell Engineering Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cell Engineering Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cell Engineering Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cell Engineering Service Revenue by Application (2027-2032)
  9. 11.5 Asia Cell Engineering Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cell Engineering Service Revenue by Country
  11. 11.6.1 Asia Cell Engineering Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cell Engineering Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cell Engineering Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cell Engineering Service Revenue (2021-2032)
  2. 12.2 SAMEA Cell Engineering Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cell Engineering Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cell Engineering Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cell Engineering Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cell Engineering Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cell Engineering Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cell Engineering Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cell Engineering Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cell Engineering Service Revenue by Country
  11. 12.6.1 SAMEA Cell Engineering Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cell Engineering Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cell Engineering Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research